Yaminali M Javid, MD
Pediatric Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Javid’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$3,010 in 2024
Medicaid paid $3,010 for 518 billed services this clinician did in 2024, up to 59 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 423 | $1,394 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 12 | $886 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 24 | $226 |
| Pure tone audiometry (threshold); air only | 28 | $219 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 19 | $172 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 12 | $113 |
| 2024 | 518 | 6 | 59 | $3,010 |
| 2023 | 1,994 | 14 | 66 | $37,958 |
| 2022 | 2,302 | 17 | 49 | $45,226 |
| 2021 | 2,171 | 17 | 82 | $44,259 |
| 2020 | 2,560 | 19 | 85 | $50,465 |
| 2019 | 4,249 | 22 | 99 | $72,812 |
| 2018 | 3,410 | 22 | 79 | $53,674 |
See the largest Medicaid services in earlier years
2023
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 221 | $8,198 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 103 | $6,384 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 133 | $5,481 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 244 | $5,305 |
| Pure tone audiometry (threshold); air only | 306 | $4,883 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 66 | $3,567 |
| Short return visit (20+ min) | 571 | $1,189 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 121 | $918 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 92 | $845 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 58 | $565 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 26 | $198 |
| Varicella virus vaccine (VAR), live, for subcutaneous use | 25 | $198 |
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 175 | $8,794 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 261 | $8,435 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 178 | $7,788 |
| Pure tone audiometry (threshold); air only | 367 | $5,459 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 251 | $5,100 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 80 | $4,116 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 124 | $1,151 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 124 | $1,151 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 81 | $731 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 54 | $472 |
| Short return visit (20+ min) | 396 | $420 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 49 | $364 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 312 | $10,682 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 169 | $9,155 |
| Pure tone audiometry (threshold); air only | 366 | $5,226 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 227 | $4,376 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 100 | $3,845 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 63 | $3,204 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 185 | $1,623 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 170 | $1,509 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 80 | $1,239 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 47 | $945 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 54 | $461 |
| Short return visit (20+ min) | 197 | $420 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 326 | $18,289 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 266 | $8,974 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 180 | $3,606 |
| Pure tone audiometry (threshold); air only | 229 | $3,408 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 85 | $3,362 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 216 | $1,831 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 218 | $1,810 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 197 | $1,750 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 102 | $1,691 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 66 | $1,491 |
| Short return visit (20+ min) | 335 | $1,189 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 14 | $912 |
2019
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 342 | $19,159 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 411 | $13,447 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 172 | $7,424 |
| Pure tone audiometry (threshold); air only | 394 | $5,504 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 314 | $5,187 |
| Short return visit (20+ min) | 939 | $4,592 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 62 | $3,473 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 310 | $2,428 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 300 | $2,350 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 121 | $2,055 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 186 | $1,532 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 84 | $1,298 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 318 | $13,767 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 300 | $11,621 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 87 | $4,298 |
| Pure tone audiometry (threshold); air only | 275 | $3,958 |
| Short return visit (20+ min) | 880 | $3,501 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 277 | $2,563 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 276 | $2,542 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 191 | $1,918 |
| New patient visit (30+ min) | 26 | $1,909 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 66 | $1,301 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 242 | $1,262 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 125 | $1,193 |
Money from drug and device companies
$64 in 2025
| 2025 | 2 | 3 | None | $64 |
| 2024 | 1 | 2 | None | $17 |
| 2023 | 1 | 2 | None | $27 |
| 2022 | 2 | 2 | None | $43 |
| 2021 | 1 | 1 | None | $21 |
| 2020 | 2 | 2 | None | $39 |
| 2019 | 1 | 2 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biogen | Zurzuvae | $46 | 2 payments
|
| CooperSurgical | Paragard T 380a | $19 | 1 payment
|
See all 3 published payments
| Biogen | Meals · 2025-09-23 | Zurzuvae | $26 |
| CooperSurgical | Meals · 2025-04-22 | Paragard T 380a | $19 |
| Biogen | Meals · 2025-04-08 | Zurzuvae | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $17
| Cranial Technologies | Doc Band | $17 | 2 payments
|
2023: $27
| Cranial Technologies | Doc Band | $27 | 2 payments
|
2022: $43
| Organon | Nexplanon | $24 | 1 payment
|
| Cranial Technologies | Doc Band | $20 | 1 payment
|
2021: $21
| Exeltis USA | Slynd | $21 | 1 payment
|
2020: $39
| Roche Diagnostics | Rs Harmony Test Related Products | $20 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $19 | 1 payment
|
2019: $32
| Merck Sharp & Dohme | Rotateq | $32 | 2 payments
|
Professional record
- NPI
- 1952465361
- Licence
- CA A046602
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A046602
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 125 N Jackson Ave, Suite #206, San Jose, CA, 95116
- NPI first listed
- 2006-12-20
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.